Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zarnestra in Relapsed/Refractory Mantle Cell Lymphoma
NCT00847223Phase 2Terminated
- Sponsor
- Lymphoma Study Association
- Start
- Jun 2007
- Primary completion
- Mar 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tipifarnib in mantle cell lymphoma (MCL), sponsored by Lymphoma Study Association. Started Jun 2007; status: terminated.
02
Drugs
tipifarnib
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00847223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00847223.